,0,1
0,[1],"The first quarter of 2015 included charges of $29 million related to business optimization, Gambro integration costs, and separation-related costs. The second quarter of 2015 included benefits of $5 million related to business optimization, Gambro integration costs, separation-related costs, and tax and legal reserves. The third quarter of 2015 included charges of $191 million related to business optimization, Gambro integration costs, separation-related costs, a loss on debt extinguishment, and product-related items. The fourth quarter of 2015 included $17 million related to business optimization, Gambro integration costs, product-related items, separation-related costs, and reserve items and adjustments."
1,[2],"The first quarter of 2014 included charges of $46 million related to business optimization, Gambro integration costs, tax and legal reserves, and milestone payments associated with the company's collaboration arrangements. The second quarter of 2014 included charges of $78 million related to business optimization, Gambro integration costs, product-related items, and tax and legal reserves. The third quarter of 2014 included charges of $43 million related to business optimization, Gambro integration costs, and the Branded Prescription Drug Fee. The fourth quarter of 2014 included $47 million related to business optimization, Gambro integration costs, product-related items, separation-related costs, and tax and legal reserves."
